You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
Nexus Pharmaceuticals Seeks New Trial Following Exela's Clearance in $89M IP Case Nexus Pharmaceuticals has filed a request with a Delaware federal judge for a new trial regarding its patent infringe... Read the full IIPLA article: https://iipla.org/news/nexus-pharmaceuticals-seeks-new-trial-following-exelas-clearance-in-89m-ip-case